Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 0.03% | 705.60 | 2.6% | $682.64m | |
| AMGN | Amgen, Inc. | -0.51% | 229.80 | 1.4% | $637.83m | |
| MRNA | Moderna, Inc. | -0.45% | 121.60 | 0.0% | $630.90m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 63.93 | 1.0% | $522.23m | |
| BIIB | Biogen, Inc. | -2.01% | 271.05 | 1.8% | $454.14m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.17% | 291.91 | 1.9% | $390.67m | |
| ILMN | Illumina, Inc. | -1.93% | 197.40 | 3.2% | $317.46m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 4.37 | 0.7% | $305.48m | |
| SAVA | Cassava Sciences, Inc. | 0.96% | 44.26 | 0.0% | $196.86m | |
| BNTX | BioNTech SE | -1.11% | 132.30 | 0.0% | $108.50m | |
| NVAX | Novavax, Inc. | -0.92% | 19.43 | 75.6% | $89.24m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.00% | 85.84 | 4.2% | $84.06m | |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 0.08% | 13.35 | 0.0% | $76.94m | |
| TECH | Bio-Techne Corp. | 0.00% | 289.65 | 4.5% | $75.91m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 34.44 | 17.6% | $74.81m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.